Literature DB >> 4045231

Shigella septicemia: prevalence, presentation, risk factors, and outcome.

M J Struelens, D Patte, I Kabir, A Salam, S K Nath, T Butler.   

Abstract

The prevalence, presentation, and outcome of bacteremia due to Shigella and other gram-negative bacteria were determined by review of records of 2,018 inpatients with shigellosis who had their blood cultured in a Bangladeshi hospital in 1976-1983. Shigella bacteremia occurred in 82 (4.1%) patients; other bacteremia occurred in 102 (5.1%) patients. Patients with shigella sepsis more frequently (P less than .02) manifested severe dehydration, abdominal tenderness or ileus, agitation or lethargy, and leukocytosis than did nonbacteremic controls; they developed more frequently (P less than .05) renal failure (26%), leukemoid reaction (22%), thrombocytopenia (20%), and hemolytic-uremic syndrome (6%). The prevalence of all bacteremia was highest in the first year of life. Protein-energy malnutrition was a strong risk factor for shigella sepsis (P less than .01). The fatality rate in shigella bacteremia (21%) was higher (P less than .005) than in nonbacteremic shigellosis (10%) but lower (P less than .001) than in other bacteremia (51%). At highest risk of death from shigella bacteremia (P less than .01) were patients less than one year old, non-breast-fed, malnourished, and afebrile.

Entities:  

Mesh:

Year:  1985        PMID: 4045231     DOI: 10.1093/infdis/152.4.784

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

Review 1.  Shigella: a model of virulence regulation in vivo.

Authors:  Benoit Marteyn; Anastasia Gazi; Philippe Sansonetti
Journal:  Gut Microbes       Date:  2012-03-01

2.  Toxic dilatation of the colon in shigellosis.

Authors:  A P Wilson; G L Ridgway; M Sarner; P B Boulos; M G Brook; G C Cook
Journal:  BMJ       Date:  1990-12-08

Review 3.  Common themes in microbial pathogenicity.

Authors:  B B Finlay; S Falkow
Journal:  Microbiol Rev       Date:  1989-06

4.  An update on vaccines against Shigella.

Authors:  Shai Ashkenazi; Dani Cohen
Journal:  Ther Adv Vaccines       Date:  2013-09

Review 5.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 6.  Shigellemia in AIDS patients: case report and review of the literature.

Authors:  J Huebner; W Czerwenka; E Gruner; A von Graevenitz
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

7.  Induction of adherence and degranulation of polymorphonuclear leukocytes: a new expression of the invasive phenotype of Shigella flexneri.

Authors:  P Renesto; J Mounier; P J Sansonetti
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

8.  Comparative virulence of blood and stool isolates of Shigella sonnei.

Authors:  C Seymour; H M Crowe; M E Wilson
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

9.  Shigella bacteraemia in adults.

Authors:  A J Trevett; B O Ogunbanjo; S Naraqi; J D Igo
Journal:  Postgrad Med J       Date:  1993-06       Impact factor: 2.401

10.  Shigellosis in the south-western Cape of Good Hope 1968-85.

Authors:  P R Donald; M L Pretorius; P J Burger
Journal:  Epidemiol Infect       Date:  1987-04       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.